The TGF-beta signaling pathway controls multiple functions of cancer cells and the surrounding stromal tissue. Some TGF-beta actions suppress cancer formation, while others contribute to tumor progression. Evidence supporting a tumor suppressive role for the TGFbeta/Smad signaling axis is presented here. These data are compiled from cell culture studies, animal models, analyses of human tumors, and investigations of polymorphisms of TGF-beta pathway components and their associated cancer risk. Therapeutic strategies for cancer treatment involving either restoring or potentiating TGF-beta tumor suppressive activities, or blocking TGF-beta tumor promoting functions are considered.
Mendeley helps you to discover research relevant for your work.
CITATION STYLE
Jahn, S. C., Law, M. E., Corsino, P. E., & Law, B. K. (2012). TGF-beta antiproliferative effects in tumor suppression. Frontiers in Bioscience - Scholar, 4 S(2), 749–766. https://doi.org/10.2741/s297